NTRK1 and sarcoma: Another recent study reviewed NTRK fusion positive sarcomas and showed, based on next-generation sequencing and fluorescence in situ hybridization, that they highly express Trk protein [41] which is responsible of the activation of a number of key downstream intracellular pathways, including the MAPK pathway (reviewed elsewhere: see: [46]).